These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 7503067

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
    Mackenzie RK, Jones S, Moseley A, Holmes CJ, Argyle R, Williams JD, Coles GA, Pu K, Faict D, Topley N.
    Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
    [Abstract] [Full Text] [Related]

  • 4. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, Faict D, Topley N.
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [Abstract] [Full Text] [Related]

  • 5. In vitro effects of low-calcium peritoneal dialysis solutions on peritoneal macrophage functions.
    Kiefer T, Schenk U, Hübel E, Weber J, Mettang T, Passlick-Deetjen J, Kuhlmann U.
    Am J Kidney Dis; 1995 May; 25(5):751-60. PubMed ID: 7747729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
    MacKenzie RK, Holmes CJ, Moseley A, Jenkins JP, Williams JD, Coles GA, Faict D, Topley N.
    J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
    [Abstract] [Full Text] [Related]

  • 8. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J, Schoenicke G, Grabensee B.
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [Abstract] [Full Text] [Related]

  • 9. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
    Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, Passlick-Deetjen J, Rutkowski B.
    Perit Dial Int; 2002 Sep; 22(6):663-9. PubMed ID: 12556067
    [Abstract] [Full Text] [Related]

  • 10. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M, Keuning ED, ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J.
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [Abstract] [Full Text] [Related]

  • 11. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity.
    Thomas S, Schenk U, Fischer FP, Mettang T, Passlick-Deetjen J, Kuhlmann U.
    Am J Kidney Dis; 1997 Feb; 29(2):246-53. PubMed ID: 9016897
    [Abstract] [Full Text] [Related]

  • 12. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T, Ishii H, Kitano T, Shindo M, Miyazawa H, Yamada H, Ito K, Ueda Y, Kaku Y, Hirai K, Mori H, Ookawara S, Tabei K, Morishita Y.
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [Abstract] [Full Text] [Related]

  • 13. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF, Dekker HA, Oe PL, Verbeelen D, ter Wee PM, Verbrugh HA.
    Nephron; 1996 Feb; 74(1):26-32. PubMed ID: 8883016
    [Abstract] [Full Text] [Related]

  • 14. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A, Bender TO, Finn A, Witowski J, Fröhlich S, Gahl GM, Frei U, Keck H, Passlick-Deetjen J.
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS.
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [Abstract] [Full Text] [Related]

  • 17. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
    de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Verhoef J, Donker AJ.
    Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
    [Abstract] [Full Text] [Related]

  • 18. Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis.
    de Fijter CW, Oe LP, Heezius EC, Donker AJ, Verbrugh HA.
    Am J Kidney Dis; 1996 Mar; 27(3):409-15. PubMed ID: 8604711
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
    Topley N, Kaur D, Petersen MM, Jörres A, Passlick-Deetjen J, Coles GA, Williams JD.
    Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.